IBC Life Sciences, in conjunction with Select Greater Philadelphia, is pleased to announce its Translational Medicine Conference will be held May 1-2, 2006 in Philadelphia, Pennsylvania. This conference provides proven activities to enable early clinical development from today’s leaders in the industry. The program further examines the optimum use of biomarkers and bioimaging technologies as useful predictor models for safety, efficacy and compound behavior to increase the probability for early attrition and decrease late-phase attrition. Also, examples of how companies are employing translational medicine and incorporating and utilizing this information to shorten cycle time, reduce risk, and make better decisions are explored.
